Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Fetal environments contain various chemicals that may disrupt hormones.

Fasting may reduce chemotherapy side effects.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Glibenclamide slows breast cancer cell growth by stopping cell division.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Skin health and diseases are closely linked to metabolic processes.